ArticlePloS one2025

CD38-targeted attenuated interferon alpha immunocytokine activates both innate and adaptive immune cells to drive anti-tumor activity.

James F Sampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.